Cargando…

Development and Research Progress of Anti-Drug Resistant Bacteria Drugs

Bacterial resistance has become increasingly serious because of the widespread use and abuse of antibiotics. In particular, the emergence of multidrug-resistant bacteria has posed a serious threat to human public health and attracted the attention of the World Health Organization (WHO) and the gover...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Xiangyi, Lü, Yuhong, Yue, Changwu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711564/ https://www.ncbi.nlm.nih.gov/pubmed/34992385 http://dx.doi.org/10.2147/IDR.S338987

Ejemplares similares

Research progress of anti-glioma chemotherapeutic drugs
por: Zhou, Yi-Shu, et al.
Publicado: (2022)

Hsp90 Inhibitors and the Reduction of Anti-Cancer Drug Resistance by Non-Genetic and Genetic Mechanisms
por: Lu, Xiangyi, et al.
Publicado: (2012)

Progress in Anti-Mammarenavirus Drug Development
por: Kim, Yu-Jin, et al.
Publicado: (2021)

Research and development of Chinese anti-COVID-19 drugs
por: Ji, Xiwei, et al.
Publicado: (2022)

Progress in the Research and Development of Anti-COVID-19 Drugs
por: Huang, Lianzhou, et al.
Publicado: (2020)

The Development of the Bengamides as New Antibiotics against Drug-Resistant Bacteria
por: Porras-Alcalá, Cristina, et al.
Publicado: (2022)

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Progress in Small Molecule Drug Development
por: Rao, Praveen P. N., et al.
Publicado: (2010)

Drug resistance: from bacteria to cancer
por: Patel, Harsh, et al.
Publicado: (2021)

Challenges and Progress in Nonsteroidal Anti-Inflammatory Drugs Co-Crystal Development
por: Nugrahani, Ilma, et al.
Publicado: (2021)

Research progress on the relationship between lung cancer drug-resistance and microRNAs
por: Ma, Xuan, et al.
Publicado: (2019)

Epidemiology and Mechanisms of Resistance of Extensively Drug Resistant Gram-Negative Bacteria
por: Eichenberger, Emily M., et al.
Publicado: (2019)

The Recent Research Progress of NF-κB Signaling on the Proliferation, Migration, Invasion, Immune Escape and Drug Resistance of Glioblastoma
por: Shi, Pengfei, et al.
Publicado: (2023)

Research progress on non-protein-targeted drugs for cancer therapy
por: Zhang, Yiwen, et al.
Publicado: (2023)

PBPK modeling and simulation in drug research and development
por: Zhuang, Xiaomei, et al.
Publicado: (2016)

Research Progress on the Role of ABC Transporters in the Drug Resistance Mechanism of Intractable Epilepsy
por: Xiong, Jie, et al.
Publicado: (2015)

Marine Antibody–Drug Conjugates: Design Strategies and Research Progress
por: Wang, Yu-Jie, et al.
Publicado: (2017)

Anti-trypanosomatid drug discovery: progress and challenges
por: De Rycker, Manu, et al.
Publicado: (2022)

Plant Secondary Metabolites in the Battle of Drugs and Drug-Resistant Bacteria: New Heroes or Worse Clones of Antibiotics?
por: Gorlenko, Cyrill L., et al.
Publicado: (2020)

R-Loops and R-Loop-Binding Proteins in Cancer Progression and Drug Resistance
por: Elsakrmy, Noha, et al.
Publicado: (2023)

Bedbugs as Vectors for Drug-Resistant Bacteria
por: Lowe, Christopher F., et al.
Publicado: (2011)

Ovarian cancer: epigenetics, drug resistance, and progression
por: Xie, Weiwei, et al.
Publicado: (2021)

Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2
por: Fan, Shiyong, et al.
Publicado: (2020)

Progress of Research into Novel Drugs and Potential Drug Targets against Porcine Pseudorabies Virus
por: Zhou, Mo, et al.
Publicado: (2022)

Pulling the Brakes on Fast and Furious Multiple Drug-Resistant (MDR) Bacteria
por: Khan, Abid Ali, et al.
Publicado: (2021)

How Phages Overcome the Challenges of Drug Resistant Bacteria in Clinical Infections
por: Taati Moghadam, Majid, et al.
Publicado: (2020)

Antimicrobial Peptides Therapy: An Emerging Alternative for Treating Drug-Resistant Bacteria
por: Mba, Ifeanyi Elibe, et al.
Publicado: (2022)

Research in the Field of Drug Design and Development
por: Biala, Grazyna, et al.
Publicado: (2023)

Research and development of drug delivery systems based on drug transporter and nano-formulation
por: Peng, Yi, et al.
Publicado: (2020)

Research progress of in-situ gelling ophthalmic drug delivery system
por: Wu, Yumei, et al.
Publicado: (2019)

Phosphoethanolamine Transferases as Drug Discovery Targets for Therapeutic Treatment of Multi-Drug Resistant Pathogenic Gram-Negative Bacteria
por: Thai, Van C., et al.
Publicado: (2023)

A review of research progress of antitumor drugs based on tubulin targets
por: Cheng, Ziqi, et al.
Publicado: (2020)

Bacteriophage as a Novel Therapeutic Weapon for Killing Colistin-Resistant Multi-Drug-Resistant and Extensively Drug-Resistant Gram-Negative Bacteria
por: Mousavi, Seyed Mohammad, et al.
Publicado: (2021)

Nanoparticles as therapeutic options for treating multidrug-resistant bacteria: research progress, challenges, and prospects
por: Mba, Ifeanyi E., et al.
Publicado: (2021)

Bacteria exposed to antiviral drugs develop antibiotic cross-resistance and unique resistance profiles
por: Wallace, Veronica J., et al.
Publicado: (2023)

Anti-HBV Drugs: Progress, Unmet Needs, and New Hope
por: Kang, Lei, et al.
Publicado: (2015)

Anti-Obesity Drug Delivery Systems: Recent Progress and Challenges
por: Ashour, Mohamed M., et al.
Publicado: (2023)

Drug Development for Alzheimer's Disease: Recent Progress
por: Ji, Wonjin, et al.
Publicado: (2010)

Research Progress of Drug Treatment in Novel Coronavirus Pneumonia
por: Yan, Junqiang, et al.
Publicado: (2020)

Bacteriophages: A Therapy Concept against Multi-Drug–Resistant Bacteria
por: Rohde, Christine, et al.
Publicado: (2018)

Next-generation strategy for treating drug resistant bacteria: Antibiotic hybrids
por: Gupta, Varsha, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fkmtgs8sorfj6gv07v3punf7vd